coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Weald PCN, Tunbridge Wells · Health Inequalities Profile

    PCN U92096 · NHS Kent and Medway Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    47,681

    Registered population

    55.9% aged 18–64

    23.7%

    Aged 65+

    ICB 19.9% · England 17.9%

    3.9%

    Ethnic minority (non-White)

    1.2% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    7,679

    Hypertension register

    +6.63% in 3 yrs · England +5.60%

    339

    SMI register

    26.2% of Tunbridge Wells'

    848

    COPD register

    Reviews -0.75% in 3 yrs

    Forecast to 2030

    9,611

    Hypertension patients, 2096

    +1,932 on today

    66.2%

    QRISK ≥20% on statins, 2096

    +2.80pp over 3 yrs

    6.6%

    Cancer prevalence, 2096

    England 4.5%

    Three things the board should see

    59.9%
    Heart failure and blood pressure reviews lag.

    Heart failure reviews are 59.9% (-8.7% over 2023 to 2025 vs England +8.7%) and under-80 BP control is 62.5% (-5.0% vs England +3.2%).

    58.3%
    Asthma annual reviews trail England benchmark.

    Annual asthma reviews reach 58.3% (England 65.7%) across 2,937 patients, leaving about 1,200 unreviewed, which may reflect recall gaps to verify locally.

    90.3%
    Strong severe mental illness checks and screening.

    SMI blood pressure checks reach 90.3% (+11.6 pp over 2023 to 2025 vs England +4.4 pp) alongside 76.8% cervical screening (England 66.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    An older population with 23.7% aged 65+ may increase complex care requirements

    WEALD PCN serves 47,681 registered patients across eight practices. The population is older than benchmarks: 23.7% (11,312 patients) are aged 65+, compared with 20.2% in Tunbridge Wells, 19.9% in NHS Kent and Medway ICB, and 17.9% in England. Working-age adults aged 18–64 represent 55.9% (26,660) and children aged 0–17 comprise 20.4% (9,709). Projected list growth to 2030 is 7.1%, above Tunbridge Wells (5.3%), the ICB (6.0%), and England (2.3%), using unverified methodology. By Census resident data, 96.1% identify as White (Tunbridge Wells 91.5%, ICB 88.6%, England 81.1%), leaving a 3.9% ethnic minority share.

    Age profile

    0–1720.4%
    18–6455.9%
    65+23.7%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White96.1%
    Mixed1.7%
    Asian1.2%
    Black0.5%
    Other0.4%

    Older people · falls rows are Tunbridge Wells local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Tunbridge Wells LA)2,5992,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.2%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.2%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Tunbridge Wells LA)1,4549819552024/25
    Falls deaths, all ages, per 100,000 (Tunbridge Wells LA)12.414.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    WEALD PCN records 0.0% Core20 patients and an average IMD decile of 5.6

    WEALD PCN records 0.0% of its 47,681 registered patients in national IMD quintile 1 (Tunbridge Wells 2.7%, ICB 17.1%, England 21.0%), yielding an estimated Core20 count of 0. Across all eight member practices, both Core20 concentration (0.0% share) and absolute volume (0 patients) reconcile to 0.0% with 0 associated decile 1 or 2 LSOAs. The average IMD decile is 5.6 (Tunbridge Wells 6.8, ICB 5.4, England 5.5). With zero Core20 patients across national deciles 1 and 2, health inequalities initiatives require non-Core20 targeting across vulnerable cohorts.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Weald View0.0% · 0 patients
    Yalding0.0% · 0 patients
    Howell0.0% · 0 patients
    Lamberhurst0.0% · 0 patients
    Marden0.0% · 0 patients
    Old Parsonage0.0% · 0 patients
    Old School0.0% · 0 patients
    Orchard End0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    339

    SMI register

    0.72% recorded prevalence

    208

    Learning disability register

    0.44% recorded prevalence

    17

    Care homes, 577 beds

    In the PCN catchment

    7.9%

    Provide unpaid care

    Tunbridge Wells, Census 2021

    Recorded learning disability is 0.4% (208 patients) and severe mental illness is 0.7% (339 patients), trailing Tunbridge Wells (0.6% and 1.0%), the ICB (0.6% and 0.9%), and England (0.6% and 1.0%). Catchment care homes total 17 (577 beds), alongside 0.7% Gypsy or Irish Traveller residents (England 0.1%). Crude register differences do not confirm under-detection; clinical audits could verify whether case-finding or demography explains lower recorded rates.

    Severe mental illness: physical health checks

    Annual SMI checks exceed England for blood pressure (90.3% vs 83.4%) and BMI (89.5% vs 82.1%). However, smoking cessation support fell 3.2 pp over 2023 to 2025 (England +0.1 pp) to 90.7% (England 94.2%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,679

    Hypertension register

    +6.63%

    Register growth, 3 yrs

    Tunbridge Wells +5.38% · England +5.60%

    −3.30pp

    BP control, under 80

    ≤140/90 · −1.43pp aged 80+

    +1,932

    More patients by 2030

    Forecast 9,611 (18.47%)

    Hypertension case-finding and control

    WEALD PCN records 7,679 hypertension patients (16.2% vs Tunbridge Wells 14.8%, England 15.2%), growing +6.6% over 2023 to 2025 (England +5.6%). Recent blood pressure recording reaches 87.1% (Tunbridge Wells 85.9%, England 90.0%), but treated to target is 66.7% (Tunbridge Wells 65.1%, England 70.3%) and under-80 control fell 5.0% over 2023 to 2025 (England +3.2%) to 62.5% (England 67.8%). Heart failure reviews including functional capacity also fell 8.7% over 2023 to 2025 (England +8.7%) to 59.9% (England 78.5%) across 469 patients. Control and review rates lag England despite register growth, suggesting clinical review and titration protocols warrant priority across practices to close management gaps.

    Lipids and statins

    For patients with QRISK ≥ 20%, 60.2% receive lipid-lowering therapy (Tunbridge Wells 56.6%, England 63.6%), rising +4.9% over 2023 to 2025 (England +6.2%). Diabetes statin treatment without cardiovascular disease is 71.5% (England 73.2%), falling 3.0% over 2023 to 2025 (England +2.1%). Primary prevention recalls may help address lower coverage among at-risk cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026106,666£1.80£1.90£1.86£191,999
    Cardiovascular (all), 2025134,257£2.86£3.57£3.33£383,975

    In 2026, the PCN prescribed 106,666 lipid-regulating items at £1.80 per item (Tunbridge Wells £1.73, England £1.86, NHS Kent and Medway ICB £1.90), spending £6,400 less than at England's unit cost. Lower unit costs than England show favorable item expenditure, allowing the PCN to prioritize clinical coverage over formulary switching.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.01%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.10%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.6% (2,937 patients, England 6.6%), but 12-month reviews stand at 58.3% (England 65.7%; 3-year change -0.01% vs England +4.4%), leaving about 1,200 patients without a recorded review. Second-hand smoking recording for asthma patients aged 6–19 is 74.4% (279 patients, England 78.8%). Recorded COPD prevalence is 1.8% (848 patients, England 1.9%), with annual reviews at 69.2% (England 76.4%; 3-year change -0.8% vs England +2.8%). Proactive recall across respiratory registers could help close these review delivery gaps.

    Cancer register and children's immunisation

    Cancer register prevalence is 5.3% (2,517 patients), above England (3.8%). In Q1 2025/26 childhood immunisations, 6-in-1 coverage is 94.1% at 12 months and 89.6% at 24 months. At age 5, MMR dose 1 achieves 96.1% (above the 95.0% target), but dose 2 is 88.2% (a 7.9 pp dose difference), and 4-in-1 booster coverage is 88.2%. Timely recall between primary and pre-school boosters may help protect herd immunity.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.1%

    England 91.0%

    6-in-1 complete primary course at 24 months89.6%

    England 92.2%

    MMR dose 1 at 24 months89.6%

    England 88.3%

    MMR dose 2 at age 588.2%

    England 82.8%

    4-in-1 pre-school booster at age 588.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In NHS Kent and Medway ICB, 55.6% of staged cancers were diagnosed at stage 1 or 2 in 2022 (4,661 of 8,384), matching England (55.3%) but 19.4 pp below the 75.0% national ambition by 2028. Known-stage coverage was 63.6% (8,384 of 13,189 registered cancers), trailing England (67.0%). Reaching the ambition requires about 1,630 extra early diagnoses annually. WEALD PCN records 76.8% cervical screening (England 66.8%) and 70.3% breast screening (England 69.9%), while Old School Surgery fell 11.8% (England -1.0%) over 2023 to 2025 to 72.1%. Maximising screening uptake supports the wider system staging ambition.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Maidstone and Tunbridge Wells NHS Trust met all three captured cancer waiting standards, achieving 87.4% on the 62-day referral to treatment standard (above the 85.0% standard by 2.4 pp), 81.8% on the 28-day faster diagnosis standard (above 75.0% by 6.8 pp), and 98.3% on the 31-day combined treatment standard (above 96.0% by 2.3 pp). Across NHS Kent and Medway Integrated Care Board, 62-day performance was 75.9% (below the 85.0% standard by 9.1 pp). For WEALD PCN's 2,517 cancer register patients, strong local acute compliance suggests timely diagnostic and treatment management once referrals enter secondary care.

    Pathways within standard (%)Maidstone and Tunbridge WellsEast Sussex HealthcareMedwayKent and Medway ICBEngland
    28-day faster diagnosis (75%)81.7884.2077.7776.7879.32
    31-day treatment (96%)98.3598.1999.6295.8492.50
    62-day referral to treatment (85%)87.4367.0481.6475.9371.16
    Diagnostic waits over 6 weeks (%)Maidstone and Tunbridge WellsEast Sussex HealthcareMedwayEngland
    MRI0.926.480.6821.40
    CT0.510.480.009.92
    Echocardiography2.5721.9436.6228.48
    Colonoscopy19.800.741.8830.83
    Gastroscopy24.030.313.3229.02
    All 15 DM01 tests6.425.2714.2023.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In the Community Services Dataset (Jun 2026 (provisional)), adults aged 65+ accounted for 65.8% of community contacts for borough residents (138,250 of 210,170 contacts), though provider-level activity was not captured. With 23.7% of WEALD PCN's list aged 65+, this pattern points to substantial reliance on community health teams to manage frailty and complex long-term conditions locally.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Orchard End870.083.6%66.0%97.1%
    Old Parsonage1090.086.9%76.1%96.9%
    Lamberhurst1190.078.1%80.4%94.2%
    Howell Surgery1020.092.4%69.5%94.0%
    Marden1100.083.7%79.3%93.8%
    Weald View1090.066.1%75.4%78.8%
    Yalding1070.054.1%70.6%74.5%
    Old School Surgery930.053.8%83.5%69.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTunbridge WellsAssetPCNTunbridge Wells
    Care homes (catchment)17 (577 beds)n/aSchools (catchment)74n/a
    Children's centres16Places of worship8989
    Libraries69Food banks (VCS)n/a2
    Homelessness support (VCS)n/a1Day centres (VCS)35
    Children and young people (VCS)22Carers support groups (VCS)n/a4
    Primary schools (LA maintained)2724Primary academies67

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma 12-month reviews are 58.3% across 2,937 patients (Tunbridge Wells 57.1%, ICB 60.4%, England 65.7%; 3-year change -0.01% vs England +4.4%), leaving about 1,200 unreviewed. For discussion, the PCN could run structured asthma recall using a single template and flexible slots to test whether appointment access explains the gap. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Heart failure and hypertension review

    Heart failure reviews are 59.9% of 469 patients (England 78.5%, 3-year change -8.7% vs +8.7%; unadjusted register gap -10 to +55); under-80 BP control is 62.5% (England 67.8%). For discussion, the PCN could establish pharmacist-led recall and titration clinics to test whether review capacity or medicines escalation explains the lag. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Dementia register and care-home audit

    Recorded dementia is 0.7% (323 of 47,681 patients) vs England 0.8% and Tunbridge Wells 0.9% (unadjusted gap +50 to +101), while 23.7% (11,312) are aged 65+ (England 17.9%). For discussion, practices could audit records and care-home lists (17 homes, 577 beds) to test whether uncoded diagnoses explain the benchmark gap. Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older population capacity planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Non-Core20 equity focus (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI smoking cessation offer (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension control and review audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)—Practice
    Telephony and access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Heart failure and hypertension review (p12)Heart failure register · Heart Failure: QOF prevalence · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Dementia register and care-home audit (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15